Rodrigo da Silva Galhardo (Rodrigo S Galhardo)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Topics

Genome Wide Association

Circulating Tumor

Klebsiella Pneumoniae

Top Venues

Genetics and molecular biology

Microbiology spectrum

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jesus G M Pariona, Felipe Vasquez-Ponce, Johana Becerra, Thais Martins Gonçalves, Eva M M Pariona, Fabio T Madueño, Fernanda Esposito, Aline V de Lima, Jorge Luiz Mello Sampaio, Rodrigo da Silva Galhardo, Nilton Lincopán
Reversion of KPC-114 to KPC-2 in ceftazidime-avibactam- resistant/meropenem-susceptible Klebsiella pneumoniae ST11 is related to low mutation rates. Microbiology spectrum (2024)
Julia Takuno Hespanhol, Daniel Enrique Sanchez-Limache, Gianlucca Gonçalves Nicastro, Liam Mead, Edgar Enrique Llontop, Gustavo Chagas-Santos, Chuck Shaker Farah, Robson Francisco de Souza, Rodrigo da Silva Galhardo, Andrew L Lovering, Ethel Bayer-Santos
Antibacterial T6SS effectors with a VRR-Nuc domain are structure-specific nucleases. eLife 11 (2022)
Marco A Lima-Noronha, Douglas Lyra de Holanda Fonseca, Renatta S Oliveira, Rúbia R Freitas, Jung Hun Park, Rodrigo da Silva Galhardo
Sending out an SOS - the bacterial DNA damage response. Genetics and molecular biology 45 (3 Suppl 1) (2022)
Alexy O Valencia, Vânia S Braz, Magna Magalhães, Rodrigo da Silva Galhardo
Role of error-prone DNA polymerases in spontaneous mutagenesis in Caulobacter crescentus. Genetics and molecular biology 43 (1) (2020)
Frank S Fernández-Silva, Mariane L Schulz, Ingrid Reale Alves, Rubia R Freitas, Raquel Paes da Rocha, Carina O Lopes-Kulishev, Marisa H G Medeiros, Rodrigo da Silva Galhardo
Contribution of GO System Glycosylases to Mutation Prevention in Caulobacter crescentus. Environmental and molecular mutagenesis 61 (2) (2019)
Estela Ynés Valencia, Fernanda Esposito, Beny Spira, Jesús Blázquez, Rodrigo da Silva Galhardo
Ciprofloxacin-Mediated Mutagenesis Is Suppressed by Subinhibitory Concentrations of Amikacin in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 61 (3) (2017)